Commonly, MSI results from an MMR gene germline mutation (MLH1, MSH2, MSH6, PMS2; i.e., Lynch syndrome) or epigenetic inactivation of MLH1, or double somatic mutations in the MMR genes (i.e., sporadic cancers) [130, 131]. This evidence concerns the gene MLH1 and Lynch syndrome.